BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Cyber Monday Paramount+ deal: Save 50% and stream these buzzy Taylor Sheridan shows - 2Ancient mass grave discovered in water cistern during Tel Azekah excavations
- 33 Italian City Cars That Outsmarted Regulations and Rivals
- 4New materials, old physics – the science behind how your winter jacket keeps you warm
- 5Rachael Ray is navigating grief this holiday season. She doesn't have time for 'negative energy' on the internet.
- This cafe takes orders in sign language. It's cherished by the Deaf community
- Figure out How to Augment the Advantages of a Web-based Degree
- Twins were the norm for our ancient primate ancestors − one baby at a time had evolutionary advantages
- These Cities Led Global Jet-Setting In 2025, According To New Data
- What you need to know about desalination, a growing source of drinking water
- Firefighters rescue two Israelis trapped in vehicles on flooded roads in West Bank
- From blowouts to big interiors, ‘Tuscan Mom’ style is Gen Z’s answer to beige burnout
- A Republican elected governor in California? It's not as far-fetched as it sounds.
- Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts.
